Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients.

Wolters, R; Wöckel, A; Janni, W; Novopashenny, I; Ebner, F; Kreienberg, R; Wischnewsky, M; Schwentner, L

Wolters, R; Wöckel, A; Janni, W; Novopashenny, I; Ebner, F; Kreienberg, R; Wischnewsky, M; Schwentner, L.

Affiliation

Wolters R; Department of Mathematics and Computer Science, University Bremen, Universitätsallee, 28359, Bremen, Germany.

Breast Cancer Res Treat ; 142(3): 579-90, 2013 Dec.

Article in En | MEDLINE | ID: mdl-24258258

Subject(s)

Breast Neoplasms/mortality; Breast Neoplasms/pathology; Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms/therapy; Combined Modality Therapy; Female; Guideline Adherence; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2013 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google